Tildrakizumab-asmn Subcutaneous and Zolpidem Sublingual Tablets (Intermezzo)
Determining the interaction of Tildrakizumab-asmn Subcutaneous and Zolpidem Sublingual Tablets (Intermezzo) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: tildrakizumab
Brand name: Ilumya
Synonyms: Tildrakizumab
Generic Name: zolpidem
Brand name: Ambien, Ambien CR, Edluar, Intermezzo, ZolpiMist
Synonyms: Zolpidem
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Tildrakizumab-asmn Subcutaneous-Zolpidem Tablets
- Tildrakizumab-asmn Subcutaneous-Zolpidem Tartrate
- Tildrakizumab-asmn Subcutaneous-ZolpiMist
- Tildrakizumab-asmn Subcutaneous-Zolvit
- Tildrakizumab-asmn Subcutaneous-Zomacton
- Tildrakizumab-asmn Subcutaneous-Zometa
- Zolpidem Sublingual Tablets (Intermezzo)-Tilia Fe
- Zolpidem Sublingual Tablets (Intermezzo)-Tiludronate
- Zolpidem Sublingual Tablets (Intermezzo)-Timentin
- Zolpidem Sublingual Tablets (Intermezzo)-Timentin Add-Vantage
- Zolpidem Sublingual Tablets (Intermezzo)-Timentin Injection
- Zolpidem Sublingual Tablets (Intermezzo)-Timentin Novaplus